Accordingly, in tumors that naturally express both M-CSF and IL-34, or acquired the ability to produce both cytokines under certain therapeutic conditions, IL-34 has the possibility to act through interaction with M-CSF resulting in unique functions of CSF1R in both myeloid and cancer cells, which should be elucidated experimentally in further basic studies. The gene discussed is CSF1; the disease is cancer.